Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape

Мультивалентные нанотела, созданные с учётом структуры, блокируют инфекцию SARS-CoV-2 и подавляют мутационный уход
Jonathan Leo Schmid-Burgk, Ian A. Wilson, Hiroki Kato, Paul-Albert Koenig, Beate Mareike Kümmerer, Maria H. Christensen, Yonas M. Tesfamariam, Florian Ingo Schmidt, Kerstin U. Ludwig, Nicholas C. Wu, Matthias Geyer, Meng Yuan, Karl Gatterdam, Michael Schindler, Xueyong Zhu, Natalia Ruétalo, Hrishikesh Das, Hejun Liu, Florian N. Gohr, Lea‐Marie Jenster, Lisa D. J. Schiffelers, Miki Uchima, Jennifer Deborah Wuerth, Caroline I. Fandrey, Sabine Normann, Jan M. P. Tödtmann, Steffen Pritzl, Leo Hanke, Jannik Boos, B. Martin Hällberg
2021-01-12

SARS-CoV-2cryo-electron microscopymultivalent nanobodiesmutational escapereceptor-binding domain
The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread, with devastating consequences. For passive immunization efforts, nanobodies have size and cost advantages over conventional antibodies. In this study, we generated four neutralizing nanobodies that target the receptor binding domain of the SARS-CoV-2 spike protein. We used x-ray crystallography and cryo-electron microscopy to define two distinct binding epitopes. On the basis of these structures, we engineered multivalent nanobodies with more than 100 times the neutralizing activity of monovalent nanobodies. Biparatopic nanobody fusions suppressed the emergence of escape mutants. Several nanobody constructs neutralized through receptor binding competition, whereas other monovalent and biparatopic nanobodies triggered aberrant activation of the spike fusion machinery. These premature conformational changes in the spike protein forestalled productive fusion and rendered the virions noninfectious.
1
Biparatopic nanobody fusions suppressed the emergence of SARS-CoV-2 escape mutants.
2
Four neutralizing nanobodies targeting the SARS-CoV-2 spike receptor-binding domain were generated.
3
Nanobodies neutralized infection through receptor-binding competition or by inducing premature spike-fusion activation that rendered virions noninfectious.
4
Structure-guided multivalent nanobodies achieved more than 100-fold greater neutralizing activity than monovalent nanobodies.
5
X-ray crystallography and cryo-electron microscopy revealed two distinct nanobody-binding epitopes on the spike receptor-binding domain.

SARS-CoV-2 virions and their spike-protein receptor-binding domain targeted by neutralizing nanobodies

The neutralization mechanisms, potency, and suppression of mutational escape by monovalent, multivalent, and biparatopic nanobodies

Publication Details
Publication Date
2021-01-12
Journal
Publisher
ISSN
Cited by
378
Access Type
Author Information
Authors
Jonathan Leo Schmid-Burgk
Ian A. Wilson
Hiroki Kato
Paul-Albert Koenig
Beate Mareike Kümmerer
Maria H. Christensen
Yonas M. Tesfamariam
Florian Ingo Schmidt
Kerstin U. Ludwig
Nicholas C. Wu
Matthias Geyer
Meng Yuan
Karl Gatterdam
Michael Schindler
Xueyong Zhu
Natalia Ruétalo
Hrishikesh Das
Hejun Liu
Florian N. Gohr
Lea‐Marie Jenster
Lisa D. J. Schiffelers
Miki Uchima
Jennifer Deborah Wuerth
Caroline I. Fandrey
Sabine Normann
Jan M. P. Tödtmann
Steffen Pritzl
Leo Hanke
Jannik Boos
B. Martin Hällberg
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%